Back to top
more

BioSpecifics Technologies Corp (BSTC)

(Delayed Data from NSDQ)

$66.72 USD

66.72
62,398

+0.21 (0.32%)

Updated May 3, 2019 04:00 PM ET

After-Market: $66.90 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks News

Jazz's (JAZZ) Leukemia Drug Vyxeos Gets Approval in Europe

Jazz Pharmaceuticals' (JAZZ) Vyxeos receives marketing approval from the European Commission for treating acute myeloid leukemia.

    Ironwood's Linzess Gets Approval in Japan for New Indication

    Ironwood Pharmaceuticals (IRWD) along with its partner Astellas Pharma announces approval of Linzess in Japan for a new indication - chronic constipation.

      VIVUS' (VVUS) Qsymia Falters in a Highly Competitive Market

      VIVUS' (VVUS) Qsymia sales lackluster due to slow uptake of the drug and a competitive market.

        Lannett Set to Lose Distribution Agreement With Key Supplier

        Lannett Company's (LCI) distribution agreement with key supplier, Jerome Stevens Pharmaceuticals, not to be renewed on expiry. Shares plunge.

          Zacks.com highlights: PCM, STAAR Surgical, Verso, Johnson Outdoors and BioSpecifics Technologies

          Zacks.com highlights: PCM, STAAR Surgical, Verso, Johnson Outdoors and BioSpecifics Technologies

            5 Stocks With Recent Price Strength to Enhance Your Returns

            Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

              BioSpecifics Technologies (BSTC) Q2 Earnings Top Estimates

              BioSpecifics (BSTC) delivered earnings and revenue surprises of 20.41% and -0.06%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

                Can The Uptrend Continue for BioSpecifics Technologies (BSTC)?

                BioSpecifics Technologies Corp. (BSTC) has been on the move lately as the stock has risen by 8.7% in the past four weeks

                  Valeant Pharmaceuticals (VRX) Catches Eye: Stock Jumps 8.9%

                  Valeant Pharmaceuticals (VRX) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

                    What Falling Estimates & Price Mean for Adamis Pharmaceuticals (ADMP)

                    Adamis Pharmaceuticals (ADMP) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions as well.

                      Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 12.9% in Session

                      Pacira Pharmaceuticals (PCRX) was a big mover last session, as the company saw its shares rise more than 12% on Friday amid huge volumes.

                        Falling Earnings Estimates Signal Weakness Ahead for Karyopharm Therapeutics (KPTI)

                        Karyopharm Therapeutics (KPTI) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.

                          Why Flexion Therapeutics (FLXN) Could Be Positioned for a Slump

                          Flexion Therapeutics (FLXN) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.

                            Aratana Therapeutics (PETX) Soars: Stock Adds 12.4% in Session

                            Aratana Therapeutics (PETX) was a big mover last session, as the company saw its shares rise more than 12% on the day amid huge volumes.

                              Madrigal Pharmaceuticals (MDGL) Soars: Stock Adds 6.5% in Session

                              Madrigal Pharmaceuticals (MDGL) was a big mover last session, as the company saw its shares rise more than 6% on the day.

                                Nektar (NKTR) Surges: Stock Moves 11% Higher

                                Nektar (NKTR) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.

                                  ImmunoGen (IMGN) Soars: Stock Adds 10.3% in Session

                                  ImmunoGen (IMGN) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

                                    RedHill Biopharma (RDHL) in Focus: Stock Moves 10.2% Higher

                                    RedHill Biopharma (RDHL) was a big mover last session, as the company saw its shares rise more than 10% on the day.

                                      New Strong Sell Stocks for December 6th

                                      Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                        New Strong Sell Stocks for December 1st

                                        Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                          Tirthankar Chakraborty headshot

                                          New Strong Sell Stocks for November 27th

                                          Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday

                                            Tirthankar Chakraborty headshot

                                            New Strong Sell Stocks for November 22nd

                                            Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday

                                              New Strong Sell Stocks for November 17th

                                              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                                New Strong Sell Stocks for September 5th

                                                Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                                  New Strong Sell Stocks for September 1st

                                                  Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: